Home Tags DuoBody-CD3 technology

Tag: DuoBody-CD3 technology

Research associate at Genmab, Cell culturing. Photo courtesy: 2020 Genmab/Tuala Hjarnø and Torkil Stavdal

AbbVie and Genmab Sign U.S. $ 3.9 Billion Development Agreement

Peter Hofland
Chicago-based AbbVie and Genmab, headquartered in Copenhagen, Denmark, have entered into a broad oncology development program in which the companies have agreed to develop...
ADC Review, Journal of Antibody-drug Conjugates
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policymakers.

Latest

Peer Review

© 2013-2020 Sunvalley Communication, LLC. All Rights Reserved.

X